Defining genetic risk for graft-versus-host disease and mortality following allogeneic hematopoietic stem cell transplantation

Current Opinion in Hematology

Volumn 17, Issue 6, 2010, Pages 483-492

  Hansen, John A ^a   Chien, Jason W ^a   Warren, Edus H ^a   Zhao, Lue Ping ^a   Martin, Paul J ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

genome wide association studies; graft versus host disease; histocompatibility antigens; single nucleotide polymorphism; transplant related mortality

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN; MINOR HISTOCOMPATIBILITY ANTIGEN;

ACUTE GRAFT VERSUS HOST DISEASE; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; GENE DELETION; GENE FUNCTION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN GENOME; MORTALITY; PHENOTYPE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; Y CHROMOSOME;

GENETIC PREDISPOSITION TO DISEASE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS;

EID: 78049275811     PISSN: 10656251     EISSN: 15317048     Source Type: Journal    
DOI: 10.1097/MOH.0b013e32833eb770     Document Type: Review

References (82)

1. Lander ES, Linton LM, Birren B, et al. Initial sequencing and analysis of the human genome [erratum appears in Nature 2001 Aug 2; 412(6846):565 Note: Szustakowki, J [corrected to Szustakowski, J]. Nature 2001; 409:860-921.
2. Venter JC, Adams MD, Myers EW, et al. The sequence of the human genome [erratum appears in Science 2001 Jun 5; 292:1838]. Science 2001; 291:1304-1351.
3. Varmus H. Ten years on: the human genome and medicine. N Engl J Med 2010; 362:2028-2029.
4. Collins F. Has the revolution arrived? Nature 2010; 464:674-675.
5. Beatty PG, Clift RA, Mickelson EM, et al. Marrow transplantation from related donors other than HLA-identical siblings. N Engl J Med 1985; 313:765-771.
6. Beatty PG, Anasetti C, Hansen JA, et al. Marrow transplantation from unrelated donors for treatment of hematologic malignancies: effect of mismatching for one HLA locus. Blood 1993; 81:249-253.
7. Flomenberg N, Baxter-Lowe LA, Confer D, et al. Impact of HLA class I and class II high resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplant outcome. Blood 2004; 104:1923-1930.
8. Petersdorf EW, Gooley TA, Anasetti C, et al. Optimizing outcome after unrelated marrow transplantation by comprehensive matching of HLA class I and II alleles in the donor and recipient. Blood 1998; 92:3515-3520.
9. Stewart BL, Storer B, Storek J, et al. Duration of immunosuppressive treatment for chronic graft-versus-host disease. Blood 2004; 104:3501-3506.
10. Lee SJ, Klein J, Haagenson M, et al. High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation. Blood 2007; 110:4576-4583.
11. Snell GD, Dausset J, Nathenson S. Histocompatibility. New York, NY: Academic Press; 1976.
12. Elkins WL. Cellular immunology and the pathogenesis of graft versus host reactions [review]. Prog Allergy 1971; 15:78-187.
13. Perreault C, Decary F, Brochu S, et al. Minor histocompatibility antigens. Blood 1990; 76:1269-1280.
14. Martin PJ. Increased disparity for minor histocompatibility antigens as a potential cause of increased GVHD risk in marrow transplantation from unrelated donors compared with related donors. Bone Marrow Transplant 1991; 8:217-223.
15. Warren EH. The human graft-versus-tumor response: and how to exploit it. In: Appelbaum FR, Forman SJ, Negrin RS, et al., editors. Thomas' hematopoietic cell transplantation, 4th ed. Oxford, UK: Wiley-Blackwell; 2009. pp. 232-247.
16. Wang W, Meadows LR, den Haan JM, et al. Human H-Y: a male-specific histocompatibility antigen derived from the SMCY protein. Science 1995; 269:1588-1590.
17. Warren EH, Gavin MA, Simpson E, et al. The human UTY gene encodes a novel HLA-B8-restricted H-Y antigen. J Immunol 2000; 164:2807-2814.
18. Randolph SSB, Gooley TA, Warren EH, et al. Female donors contribute to a selective graft-versus-leukemia effect in male recipients of HLA-matched, related hematopoietic cell transplants. Blood 2004; 103:347-352.
19. Miklos DB, Kim HT, Miller KH, et al. Antibody responses to H-Y minor histocompatibility antigens correlate with chronic graft-versus-host disease and disease remission. Blood 2005; 105:2973-2978.
20. Loren AW, Bunin GR, Boudreau C, et al. Impact of donor and recipient sex and parity on outcomes of HLA-identical sibling allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2006; 12:758-769.
21. Stern M, Passweg JR, Locasciulli A, et al. Influence of donor/recipient sex matching on outcome of allogeneic hematopoietic stem cell transplantation for aplastic anemia. Transplantation 2006; 82:218-226.
22. Stern M, Brand R, de Witte T, et al. Female-versus-male alloreactivity as a model for minor histocompatibility antigens in hematopoietic stem cell transplantation. Am J Transplant 2008; 8:2149-2157.
23. Meadows L, Wang W, den Haan JM, et al. The HLA-A*0201-restricted H-Y antigen contains a posttranslationally modified cysteine that significantly affects T cell recognition. Immunity 1997; 6:273-281.
24. Vogt MH, de Paus RA, Voogt PJ, et al. DFFRY codes for a new human male-specific minor transplantation antigen involved in bone marrowgraft rejection. Blood 2000; 95:1100-1105.
25. Vogt MH,Goulmy E, Kloosterboer FM, et al. UTY gene codes for an HLA-B60-restricted human male-specific minor histocompatibility antigen involved in stem cell graft rejection: characterization of the critical polymorphic amino acid residues for T-cell recognition. Blood 2000; 96:3126-3132.
26. Vogt MH, van den Muijsenberg JW, Goulmy E, et al. The DBY gene codes for an HLA-DQ5-restricted human male-specific minor histocompatibility antigen involved in graft-versus-host disease. Blood 2002; 99:3027-3032.
27. Spierings E, Vermeulen CJ, Vogt MH, et al. Identification of HLA class II-restricted H-Y-specific T-helper epitope evoking CD4+ T-helper cells in H-Y-mismatched transplantation. Lancet 2003; 362:610-615.
28. Miklos DB, Kim HT, Zorn E, et al. Antibody response to DBY minor histocompatibility antigen is induced after allogeneic stem cell transplantation and in healthy female donors. Blood 2004; 103:353-359. (Pubitemid 38035116)
29. Zorn E, Miklos DB, Floyd BH, et al. Minor histocompatibility antigen DBY elicits a coordinated B and T cell response after allogeneic stem cell transplantation. J Exp Med 2004; 199:1133-1142. (Pubitemid 38619909)
30. Torikai H, Akatsuka Y, Miyazaki M, etal.A novel HLA-A*3303- restricted minor histocompatibility antigen encoded by an unconventional open reading frame of human TMSB4Y gene. J Immunol 2004; 173:7046-7054.
31. Ivanov R, Hol S, Aarts T, et al. UTY-specific TCR-transfer generates potential graft-versus-leukaemia effector T cells. Br J Haematol 2005; 129:392-402.
32. Rosinski KV, Fujii N, Mito JK, et al. DDX3Y encodes a class I MHC-restricted H-Y antigen that is expressed in leukemic stem cells. Blood 2008; 111: 4817-4826.
33. McCarroll SA, Bradner JE, Turpeinen H, et al. Donor-recipient mismatch for bull; common gene deletion polymorphisms in graft-versus-host disease. Nat Genet 2009; 41:1341-1345.
34. Xue Y, Sun D, Daly A, et al. Adaptive evolution of UGT2B17 copy-number variation. Am J Hum Genet 2008; 83:337-346.
35. Murata M, Warren EH, Riddell SR. A human minor histocompatibility antigen resulting from differential expression due to a gene deletion. J Exp Med 2003; 197:1279-1289.
36. Terakura S, Murata M, Warren EH, et al. A single minor histocompatibility antigen encoded by UGT2B17 and presented by human leukocyte antigen-A*2902 and-B*4403. Transplantation 2007; 83:1242-1248.
37. Kamei M, Nannya Y, Torikai H, et al. HapMap scanning of novel human minor histocompatibility antigens. Blood 2009; 113:5041-5048.
38. Ogawa S, Matsubara A, Onizuka M, et al. Exploration of the genetic basis of GVHD by genetic association studies (Review). Biol Blood Marrow Transplant 2009; 15 (Suppl):39-41.
39. Steemers FJ, Chang W, Lee G, et al. Whole-genome genotyping with the single-base extension assay. Nature Methods 2006; 3:31-33.
40. Gunderson KL, Steemers FJ, Lee G, et al. A genome-wide scalable SNP genotyping assay using microarray technology. Nat Genet 2005; 37:549-554.
41. Matsuzaki H, Dong S, Loi H, et al. Genotyping over 100,000 SNPs on a pair of oligonucleotide arrays. Nature Methods 2004; 1:109-111.
42. Miller RD, Phillips MS, Jo I, et al. High-density single-nucleotide polymorphism maps of the human genome. Genomics 2005; 86:117-126.
43. Gabriel SB, Schaffner SF, Nguyen H, et al. The structure of haplotype blocks in the human genome. Science 2002; 296:2225-2229.
44. Kruglyak L. The road to genome-wide association studies [review]. Nat Rev Genet 2008; 9:314-318.
45. Hakonarson H, Grant SF, Bradfield JP, et al. A genome-wide association study identifies KIAA0350 as a type 1 diabetes gene. Nature 2007; 448: 591-594.
46. Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007; 447:661-678.
47. Plenge RM, Cotsapas C, Davies L, et al. Two independent alleles at 6q23 associated with risk of rheumatoid arthritis. Nat Genet 2007; 39:1477-1482.
48. Thomson W, Barton A, Ke X, et al. Rheumatoid arthritis association at 6q23. Nat Genet 2007; 39:1431-1433.
49. International Multiple Sclerosis Genetics Consortium. Evidence for polygenic susceptibility to multiple sclerosis-the shape of things to come. Am J Hum Genet 2010; 86:621-625.
50. Perez-Garcia A, de la Camara CR, Roman-Gomez J, et al. CTLA-4 polymorphisms and clinical outcome after allogeneic stem cell transplantation from HLA-identical sibling donors. Blood 2007; 110:461-467.
51. Azarian M, Busson M, Lepage V, et al. Donor CTLA-4 +49 A/G*GG genotype is associated with chronic GVHD after HLA-identical haematopoietic stem-cell transplantations. Blood 2007; 110:4623-4624.
52. Wu J, Tang JL, Wu SJ, et al. Functional polymorphism of CTLA-4 and ICOS genes in allogeneic hematopoietic stem cell transplantation. Clin Chim Acta 2009; 403:229-233.
53. Middleton PG, Norden J, Cullup H, et al. Oestrogen receptor alpha gene polymorphism associates with occurrence of graft-versus-host disease and reduced survival in HLA-matched sib-allo BMT. Bone Marrow Transplant 2003; 32:41-47.
54. Mullighan C, Heatley S, Doherty K, et al. Non-HLA immunogenetic polymorphisms and the risk of complications after allogeneic hemopoietic stem-cell transplantation. Transplantation 2004; 27:587-596.
55. Cavet J, Middleton PG, Segall M, et al. Recipient tumor necrosis factor-alpha and interleukin-10 gene polymorphisms associate with early mortality and acute graft-versus-host disease severity in HLA-matched sibling bone marrow transplants. Blood 1999; 94:3941-3946.
56. Socie G, Loiseau P, Tamouza R, et al. Both genetic and clinical factors predict the development of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Transplantation 2001; 72:699-706.
57. Cullup H, Dickinson AM, Cavet J, et al. Polymorphisms of interleukin-1alpha constitute independent risk factors for chronic graft-versus-host disease after allogeneic bone marrow transplantation. Br J Haematol 2003; 122:778-787.
58. Mehta PA, Eapen M, Klein JP, et al. Interleukin-1 alpha genotype and outcome of unrelated donor haematopoietic stem cell transplantation for chronic myeloid leukaemia. Br J Haematol 2007; 137:152-157.
59. MacMillan ML, Radloff GA, Defor TE, et al. Interleukin-1 genotype and outcome of unrelated donor bone marrow transplantation. Br J Haematol 2003; 121:597-604.
60. Lin M-T, Storer B, Martin PJ, et al. Relation of an interleukin-10 promoter polymorphism to graft-versus-host disease and survival after hematopoietic-cell transplantation. N Engl J Med 2003; 349:2201-2210.
61. Cullup H, Dickinson AM, Jackson GH, et al. Donor interleukin 1 receptor antagonist genotype associated with acute graft-versus-host disease in human leucocyte antigen-matched sibling allogeneic transplants. Br J Haematol 2001; 113:807-813.
62. Rocha V, Franco RF, Porcher R, et al. Host defense and inflammatory gene polymorphisms are associated with outcomes after HLA-identical sibling bone marrow transplantation. Blood 2002; 100:3908-3918.
63. MacMillan ML, Radloff GA, Kiffmeyer WR, et al. High-producer interleukin-2 genotype increases risk for acute graft-versus-host disease after unrelated donor bone marrow transplantation. Transplantation 2003; 76:1758-1762.
64. Karabon L, Wysoczanska B, Bogunia-Kubik K, et al. IL-6 and IL-10 promoter gene polymorphisms of patients and donors of allogeneic sibling hemato-poietic stem cell transplants associate with the risk of acute graft-versus-host disease. Hum Immunol 2005; 66:700-710.
65. Shamim Z, Ryder LP, Heilmann C, et al. Genetic polymorphisms in the genes encoding human interleukin-7 receptor-alpha: prognostic significance in allogeneic stem cell transplantation. Bone Marrow Transplant 2006; 37:485-491.
66. Middleton PG, Taylor PRA, Jackson G, et al. Cytokine gene polymorphisms associating with severe acute graft-versus-host disease in HLA-identical sibling transplants. Blood 1998; 92:3943-3948.
67. Takahashi H, Furukawa T, Hashimoto S, et al. Contribution of TNF-alpha and IL-10 gene polymorphisms to graft-versus-host disease following allo-hema-topoietic stem cell transplantation. Bone Marrow Transplant 2000; 26:1317-1323.
68. Keen LJ, Defor TE, Bidwell JL, et al. Interleukin-10 and tumor necrosis factor alpha region haplotypes predict transplant-related mortality after unrelated donor stem cell transplantation. Blood 2004; 103:3599-3602.
69. Tseng L-H, Storer B, Petersdorf E, et al. IL 10 and IL 10 receptor gene variation and outcomes after unrelated and related hematopoietic cell transplantation. Transplantation 2009; 87:704-710.
70. Sivula J, Turpeinen H, Volin L, et al. Association of IL-10 and IL-10Rbeta gene polymorphisms with graft-versus-host disease after haematopoietic stem cell transplantation from an HLA-identical sibling donor. BMC Immunol 2009; 10:24.
71. Lin M-T, Storer B, Martin PJ, et al. Genetic variation in the IL-10 pathway modulates severity of acute graft-versus-host disease following hematopoietic cell transplantation: synergism between IL-10 genotype of patient and IL-10 receptor b genotype of donor. Blood 2005; 106:3995-4001.
72. Cardoso SM, Defor TE, Tilley LA, et al. Patient interleukin-18 GCG haplotype associates with improved survival and decreased transplant-related mortality after unrelated-donor bone marrow transplantation. Br J Haematol 2004; 126:704-710.
73. Elmaagacli AH, Koldehoff M, Landt O, et al. Relation of an interleukin-23 receptor gene polymorphism to graft-versus-host disease after hematopoie-tic-cell transplantation. Bone Marrow Transplant 2008; 41:821-826.
74. Gruhn B, IntekJ, Pfaffendorf N, et al. Polymorphism of interleukin-23 receptor gene but not of NOD2/CARD15 is associated with graft-versus-host disease after hematopoietic stem cell transplantation in children. Biol Blood Marrow Transplant 2009; 15:1571-1577.
75. Nguyen Y, Al Lehibi A, Gorbe E, et al. Insufficient evidence for association of NOD2/CARD15 or other inflammatory bowel disease-associated markers on GVHD incidence or other adverse outcomes in T-replete, unrelated donor transplantation. Blood 2010; 115:3625-3631.
76. Holler E, Rogler G, Herfarth H, et al. Both donor and recipient NOD2/ CARD15 mutations associate with transplant-related mortality and GVHD following allogeneic stem cell transplantation. Blood 2004; 104:889-894.
77. Holler E, Rogler G, Brenmoehl J, et al. Prognostic significance of NOD2/ CARD15 variants in HLA-identical sibling hematopoietic stem cell transplantation: Effect on long term outcome is confirmed in 2 independent cohorts and may be modulated by the type of gastrointestinal decontamination. Blood 2006; 107:4189-4193.
78. Holler E. The role of innate immunity in graft-versus-host disease and complications following allogeneic stem cell transplant (Review). Biol Blood Marrow Transplant 2008; 15 (Suppl):59-61.
79. Stark GL, Dickinson AM, Jackson GH, et al. Tumour necrosis factor receptor type II196 M/R genotype correlates with circulating soluble receptor levels in normal subjects and with graft-versus-host disease after sibling allogeneic bone marrow transplantation. Transplantation 2003; 76:1742-1749.
80. Middleton PG, Cullup H, Dickinson AM, et al. Vitamin D receptor gene polymorphism associates with graft-versus-host disease and survival in HLA-matched sibling allogeneic bone marrow transplantation. Bone Marrow Transplant 2002; 30:223-228.
81. Frodsham AJ, Zhang L, Dumpis U, et al. Class II cytokine receptor gene cluster is a major locus for hepatitis B persistence. PNAS 2006; 103:9148-9153.
82. Chien JW, Zhao LP, Storer B, et al. Improving hematopoietic cell transplant outcomes in a new era of genomic research. Biol Blood Marrow Transplant 2009; 15 (Suppl. 1):42-45.